Possibilities of Poly(D,L-lactide-co-glycolide) in the Formulation of Nanomedicines Against Cancer

E-ISSN： 1873-5592|12|8|1096-1111

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.8, 2011-07, pp. : 1096-1111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients

By Morlock M. Koll H. Winter G. Kissel T.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 43, Iss. 1, 1997-01 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

Stability and release characteristics of poly(d,l-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation

By Li Y. Ogris M. Pelisek J. Roedl W.

International Journal of Pharmaceutics, Vol. 269, Iss. 1, 2004-01 ,pp. : 61-70

Elsevier

Access to resources Recommend Favorite

Internal morphology of poly(d,l-lactide-co-glycolide) BCNU-loaded microspheres. Influence on drug stability

By Painbeni T. Venier-Julienne M.C. Benoit J.P.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 45, Iss. 1, 1998-01 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Reverse Micelle-Based Microencapsulation of Oxytetracycline Hydrochloride into Poly-d,l-Lactide-co-Glycolide Microspheres

By Kim Hyunjoo Lee Beom-Jin Sah Hongkee

Drug Delivery, Vol. 14, Iss. 2, 2007-02 ,pp. : 95-99

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of poly(d,l-lactide-co-glycolide) microspheres for the lung-targeting of yuanhuacine, a novel DNA topoisomerase I inhibitor

By Zhang Shixuan Gao Xiujuan Shen Kaihua Yang Puwen Ju Xiulan

Journal of Drug Targeting, Vol. 17, Iss. 4, 2009-05 ,pp. : 286-293

Informa Healthcare

Access to resources Recommend Favorite